Eli Lilly SG&A Expense (Annual) Trends

Eli Lilly and Co (LLY)

749.70 +14.73 (+2.00%) USD | NYSE | May 06, 10:08

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1984. Upgrade now.

Date	Value
December 31, 2023	6.941B
December 31, 2022	6.068B
December 31, 2021	6.142B
December 31, 2020	5.869B
December 31, 2019	6.004B
December 31, 2018	5.735B
December 31, 2017	6.180B
December 31, 2016	6.330B
December 31, 2015	6.533B
December 31, 2014	6.621B
December 31, 2013	7.126B
December 31, 2012	7.514B
December 31, 2011	7.880B
December 31, 2010	7.053B
December 31, 2009	6.892B
December 31, 2008	6.626B
December 31, 2007	6.095B
December 31, 2006	4.890B
December 31, 2005	4.497B
December 31, 2004	4.284B

Date	Value
December 31, 2003	4.055B
December 31, 2002	3.424B
December 31, 2001	3.417B
December 31, 2000	3.228B
December 31, 1999	2.758B
December 31, 1998	2.658B
December 31, 1997	2.233B
December 31, 1996	1.892B
December 31, 1995	1.854B
December 31, 1994	1.398B
December 31, 1993	3.841B
December 31, 1992	3.115B
December 31, 1991	2.303B
December 31, 1990	2.129B
December 31, 1989	1.755B
December 31, 1988	1.686B
December 31, 1987	1.746B
December 31, 1986	1.514B
December 31, 1985	1.331B
December 31, 1984	1.236B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

5.869B

Minimum

2020

6.941B

Maximum

2023

6.205B

Average

6.068B

Median

2022

SG&A Expense (Annual) Benchmarks